Smith & Nephew SNATS (SNN) Competitors

GE HealthCare Technologies (NASDAQ:GEHC) and Smith & Nephew SNATS (NYSE:SNN) are both large-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, risk, earnings, valuation, analyst recommendations, media sentiment, dividends and institutional ownership.

Is GEHC or SNN a better dividend stock?

GE HealthCare Technologies pays an annual dividend of $0.14 per share and has a dividend yield of 0.2%. Smith & Nephew SNATS pays an annual dividend of $0.89 per share and has a dividend yield of 2.5%. GE HealthCare Technologies pays out 2.9% of its earnings in the form of a dividend. Smith & Nephew SNATS pays out 41.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. GE HealthCare Technologies has raised its dividend for 1 consecutive years.

Which has higher earnings and valuation, GEHC or SNN?

GE HealthCare Technologies has higher revenue and earnings than Smith & Nephew SNATS. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Smith & Nephew SNATS, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GE HealthCare Technologies	$19.67B	1.70	$1.99B	$4.88	15.04
Smith & Nephew SNATS	$5.81B	2.73	$412M	$2.16	16.76

Do analysts rate GEHC or SNN?

GE HealthCare Technologies presently has a consensus target price of $88.55, indicating a potential upside of 20.63%. Smith & Nephew SNATS has a consensus target price of $28.00, indicating a potential downside of 22.65%. Given GE HealthCare Technologies' stronger consensus rating and higher probable upside, equities analysts clearly believe GE HealthCare Technologies is more favorable than Smith & Nephew SNATS.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GE HealthCare Technologies	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73
Smith & Nephew SNATS	0 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Does the media refer more to GEHC or SNN?

In the previous week, GE HealthCare Technologies had 27 more articles in the media than Smith & Nephew SNATS. MarketBeat recorded 29 mentions for GE HealthCare Technologies and 2 mentions for Smith & Nephew SNATS. GE HealthCare Technologies' average media sentiment score of 1.51 beat Smith & Nephew SNATS's score of 1.00 indicating that GE HealthCare Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
GE HealthCare Technologies	25 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Smith & Nephew SNATS	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more volatility & risk, GEHC or SNN?

GE HealthCare Technologies has a beta of 1.13, meaning that its stock price is 13% more volatile than the S&P 500. Comparatively, Smith & Nephew SNATS has a beta of 0.68, meaning that its stock price is 32% less volatile than the S&P 500.

Do institutionals & insiders have more ownership in GEHC or SNN?

82.1% of GE HealthCare Technologies shares are held by institutional investors. Comparatively, 25.6% of Smith & Nephew SNATS shares are held by institutional investors. 0.3% of GE HealthCare Technologies shares are held by company insiders. Comparatively, 1.0% of Smith & Nephew SNATS shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Is GEHC or SNN more profitable?

GE HealthCare Technologies has a net margin of 11.22% compared to Smith & Nephew SNATS's net margin of 0.00%. GE HealthCare Technologies' return on equity of 23.93% beat Smith & Nephew SNATS's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GE HealthCare Technologies	11.22%	23.93%	6.29%
Smith & Nephew SNATS	N/A	N/A	N/A

Summary

GE HealthCare Technologies beats Smith & Nephew SNATS on 15 of the 19 factors compared between the two stocks.